Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | 8080803 | — |
| FLU3 | INFLUENZA (SEASONAL) (FLUARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UT8488LA | — |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 5JX2E | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X028354 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y002061 | — |
Patient received Covid, Flu, MMR, Varicella, and Hep B vaccines at facility for employment. She was due now (March 2025) for her second doses and mentioned to Employee Health (reporter of this VAERS submission) that she had a "bad reaction" and wanted to "opt out" of receiving the second doses. She stated that she developed a rash on her back, neck and hairline 4-5 days after receiving the vaccines. She denies any breathing trouble with the rash she developed. She also had muscle fatigue and still has some muscle fatigue to the point her daily workout routine has been impacted. Patient never saw a provider about this but is encouraged to follow up.
Denies
Denies
Unknown
Denies
N/A- Employee Health was just made aware. The Employee said she usually "pushes through" and didn't see her PCP. I did encourage her to f/u with her PCP and I informed her I would report in VAERS.